Inhibition of beta cell growth and function by bone morphogenetic proteins

Christine Bruun(Novo Nordisk (Denmark)), Nils Billestrup(University of Copenhagen)

Diabetologia

September 26, 2014

10.1007/s00125-014-3384-8

Cited by 35

Related Papers

Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6/TAK1 Complex

|Molecular Endocrinology|2006|159

Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling

|Journal of Molecular Endocrinology|2005|131

Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1?-mediated toxicity through inhibition of multiple nuclear factor-?B-regulated proapoptotic pathways

|Diabetologia|2004|54

Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection

|Diabetologia|2008|39